Cardiac arrest often represents the first expression of an underlying cardiac disease. Despite advances in neurocritical care, the neurological assessment of cardiac arrest patients relies on clinical, instrumental and biochemical parameters. The clinical significance of S-100 calcium binding protein B (S-100B) has substantially increased throughout several areas of clinical neuroscience, but reliable evidences attest it can be used as a reliable and early predictor of poor physiological and cognitive neurological outcomes after cardiac arrest. © 2011 The Canadian Society of Clinical Chemists
ObjectivesThe aim of this study was to determine the added value of the serum biomarkers S100 and ne...
Objectives: Over the past decade, the glial protein S-100 beta has been used to detect cerebral inju...
Full list of author information is available at the end of the article S100 calcium binding protein ...
The identification of a good prognostic factor of neurological outcome after cardiac arrest is neede...
The identification of a good prognostic factor of neurological outcome after cardiac arrest is neede...
Background and purpose: Patients resuscitated from cardiac arrest (CA) have a high mortality rate. P...
International audiencePurpose: Early and reliable prognostication after cardiac arrest (CA) remains ...
BACKGROUND: The aim of this study was to determine the prognostic value and optimal sampling time of...
In an attempt to identify patients who have successfully survived a resuscitated cardiac arrest (CA)...
Background/aim: Factors affecting neurological outcome and the usefulness of neuron-specific enolase...
Background: We aimed to investigate the diagnostic performance of S100 as an outcome predictor after...
The brain-derived protein S100B is a 21 Kda dimerand have been used as a serum marker for brain dama...
Abstract Background We aimed to investigate the diagnostic performance of S100 as an outcome predict...
Early and reliable prognostication after cardiac arrest (CA) is crucial. Objectives: we hypothesized...
Inroduction: The S100B protein is a small dimeric protein which belongs to a group of calcium bindin...
ObjectivesThe aim of this study was to determine the added value of the serum biomarkers S100 and ne...
Objectives: Over the past decade, the glial protein S-100 beta has been used to detect cerebral inju...
Full list of author information is available at the end of the article S100 calcium binding protein ...
The identification of a good prognostic factor of neurological outcome after cardiac arrest is neede...
The identification of a good prognostic factor of neurological outcome after cardiac arrest is neede...
Background and purpose: Patients resuscitated from cardiac arrest (CA) have a high mortality rate. P...
International audiencePurpose: Early and reliable prognostication after cardiac arrest (CA) remains ...
BACKGROUND: The aim of this study was to determine the prognostic value and optimal sampling time of...
In an attempt to identify patients who have successfully survived a resuscitated cardiac arrest (CA)...
Background/aim: Factors affecting neurological outcome and the usefulness of neuron-specific enolase...
Background: We aimed to investigate the diagnostic performance of S100 as an outcome predictor after...
The brain-derived protein S100B is a 21 Kda dimerand have been used as a serum marker for brain dama...
Abstract Background We aimed to investigate the diagnostic performance of S100 as an outcome predict...
Early and reliable prognostication after cardiac arrest (CA) is crucial. Objectives: we hypothesized...
Inroduction: The S100B protein is a small dimeric protein which belongs to a group of calcium bindin...
ObjectivesThe aim of this study was to determine the added value of the serum biomarkers S100 and ne...
Objectives: Over the past decade, the glial protein S-100 beta has been used to detect cerebral inju...
Full list of author information is available at the end of the article S100 calcium binding protein ...